Board has approved dividend
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals' Board approved audited financial results for Q4 and FY ended March 31, 2025, with an unmodified (clean) opinion from auditor CNK & Associates LLP. Full-year revenue from operations grew sharply to Rs. 36,579 lakhs from Rs. 28,338 lakhs last year, about 29% higher. However, profit after tax declined to Rs. 1,457 lakhs from Rs. 1,884 lakhs, a roughly 23% drop, pulling down FY EPS to Rs. 19.81 from Rs. 25.62. The Board recommended a final dividend of Rs. 2.5 per share (total payout ~Rs. 184 lakhs), subject to shareholder approval. Additionally, Mr. Mukesh Malhotra, a Chartered Accountant with four decades of industry experience, was appointed as an Additional Independent Director for five years, and key Board committees were reconstituted. A proposed Rights Issue filed in September 2024 is still pending SEBI clearance, with Rs. 67.18 lakhs of related expenses shown as prepaid.
Strong top-line growth is a positive signal, but shrinking profits and weaker margins suggest rising costs are eating into earnings, which may temper investor enthusiasm. The dividend is modest and the pending Rights Issue could dilute existing shareholders if it eventually goes through.